Nothing Special   »   [go: up one dir, main page]

GB201414968D0 - Cell assay - Google Patents

Cell assay

Info

Publication number
GB201414968D0
GB201414968D0 GBGB1414968.6A GB201414968A GB201414968D0 GB 201414968 D0 GB201414968 D0 GB 201414968D0 GB 201414968 A GB201414968 A GB 201414968A GB 201414968 D0 GB201414968 D0 GB 201414968D0
Authority
GB
United Kingdom
Prior art keywords
cell assay
assay
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1414968.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Newcastle, The
Newcastle University of Upon Tyne
Original Assignee
University of Newcastle, The
Newcastle University of Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Newcastle, The, Newcastle University of Upon Tyne filed Critical University of Newcastle, The
Priority to GBGB1414968.6A priority Critical patent/GB201414968D0/en
Publication of GB201414968D0 publication Critical patent/GB201414968D0/en
Priority to PCT/GB2015/052441 priority patent/WO2016027106A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1414968.6A 2014-08-22 2014-08-22 Cell assay Ceased GB201414968D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1414968.6A GB201414968D0 (en) 2014-08-22 2014-08-22 Cell assay
PCT/GB2015/052441 WO2016027106A1 (en) 2014-08-22 2015-08-21 Cell assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1414968.6A GB201414968D0 (en) 2014-08-22 2014-08-22 Cell assay

Publications (1)

Publication Number Publication Date
GB201414968D0 true GB201414968D0 (en) 2014-10-08

Family

ID=51726961

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1414968.6A Ceased GB201414968D0 (en) 2014-08-22 2014-08-22 Cell assay

Country Status (2)

Country Link
GB (1) GB201414968D0 (en)
WO (1) WO2016027106A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060216726A1 (en) * 2004-11-16 2006-09-28 Prometheus Laboratories Inc. Method for optimizing thiopurine efficacy and toxicity using mass spectrometry
WO2014100405A1 (en) * 2012-12-19 2014-06-26 Laboratory Corporation Of America Holdings Methods and systems for determining the amount of thiopurine metabolites in a sample

Also Published As

Publication number Publication date
WO2016027106A1 (en) 2016-02-25

Similar Documents

Publication Publication Date Title
IL274903A (en) Cell
HK1246825A1 (en) Cell
HK1252162A1 (en) Cell
HK1250667A1 (en) Cell
GB201621889D0 (en) Cell
GB201507368D0 (en) Cell
GB201503500D0 (en) Cell
GB201610515D0 (en) Cell
GB201403820D0 (en) Assay
GB201603372D0 (en) Cell
SG10202004286UA (en) Integrated single cell sequencing
GB201609604D0 (en) Cell
GB201617716D0 (en) Cell
GB201415343D0 (en) Blomarker assay
PL3149792T3 (en) Lithium-sulphur cell
GB201419072D0 (en) Assay
GB201604427D0 (en) Modified cell
GB201414968D0 (en) Cell assay
GB201419493D0 (en) Assay
GB201419492D0 (en) Assay
GB201418633D0 (en) Improved assay
GB201413015D0 (en) Assay
GB201409638D0 (en) Assay
GB201408749D0 (en) Assay
GB201408724D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)